Can escitalopram (Lexapro) be taken on alternate days when reducing the dosage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tapering escitalopram by taking it on alternate days is not recommended. When reducing escitalopram dosage, it's best to gradually decrease the daily dose under medical supervision rather than skipping days. For example, if you're taking 20mg daily, your doctor might recommend reducing to 10mg daily for 1-2 weeks before further reductions, as suggested by the clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders 1.

Key Considerations

  • Alternate-day dosing creates significant fluctuations in blood levels of the medication, which can worsen withdrawal symptoms like dizziness, headaches, irritability, and "brain zaps" 1.
  • Escitalopram has a relatively short half-life of about 27-32 hours, meaning that skipping days leads to inconsistent levels in your system.
  • This approach may increase the risk of discontinuation syndrome and mood instability, characterized by symptoms such as dizziness, fatigue, lethargy, general malaise, myalgias, chills, headaches, nausea, vomiting, diarrhea, insomnia, imbalance, vertigo, sensory disturbances, paresthesias, anxiety, irritability, and agitation 1.

Recommended Approach

  • Work with your healthcare provider to create a personalized tapering schedule that might last several weeks or months depending on your current dose and how long you've been taking the medication.
  • Some people may need even more gradual reductions using liquid formulations for the smallest decrements.
  • Medical education, training, and experience are necessary to safely and effectively prescribe antidepressant medications, including tapering schedules 1.

From the Research

Escitalopram Dosage Reduction

  • The clinical pharmacokinetics of escitalopram indicate that it has an elimination half-life of about 27-33 hours, which is consistent with once-daily administration 2.
  • Steady-state concentrations of escitalopram are achieved within 7-10 days of administration, and it exhibits linear and dose-proportional pharmacokinetics following single or multiple doses in the 10-30 mg/day dose range 2.
  • When reducing the dosage of escitalopram, it is essential to consider the risk of withdrawal symptoms, which can be severe and may compel patients to recommence their medication 3.
  • Guidelines recommend tapering SSRI treatment, including escitalopram, over a period of weeks or months to minimize withdrawal symptoms 3.
  • However, there is no specific guidance on taking escitalopram on alternate days when reducing the dosage.
  • A study on tapering SSRI treatment suggests that hyperbolic tapering, which involves reducing the dose by a fixed amount at each step, may be an effective method for minimizing withdrawal symptoms 3.

Tapering Escitalopram

  • The pharmacokinetic profile of escitalopram suggests that it may be possible to taper the dose gradually without significant changes in plasma concentrations 2.
  • However, the optimal tapering schedule for escitalopram has not been established, and further research is needed to determine the most effective method for reducing the dosage while minimizing withdrawal symptoms.
  • Other studies have shown that escitalopram is effective and well-tolerated in the treatment of depression and anxiety disorders, with a rapid onset of symptom improvement and a predictable tolerability profile 4, 5, 6.
  • These studies suggest that escitalopram may be a useful treatment option for patients with major depressive disorder and anxiety disorders, but do not provide specific guidance on tapering the dosage.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.